Weekly Psychedelic Links - May 2022

5.6.22

Cannabis

• Would You Smoke ‘Nuclear Weed’? You Might Already: Why Irradiated Cannabis Is Common (And Safe) (Forbes)

• How marijuana laws have progressed across the South so far this year (Clarion Ledger)

• Stanford study links marijuana use to increased heart attack risk (New Atlas)

• A look at the legal and illegal sides of California’s cannabis industry (The Press-Enterprise)

• States that legalized marijuana now researching mental health risks of high-potency cannabis (NBC)

• ‘There’s a real risk there’: Cannabis use exacerbates depression (Healio)

• Missouri House Committee Approves Joint Resolution To Put Marijuana Legalization On The Ballot (Marijuana Moment)

• New Jersey Lawmakers File Bills To Restrict Marijuana Use By Police And Other Workers (Marijuana Moment)

• New Hampshire House Votes To Give Senate ‘Another Chance’ At Passing Marijuana Legalization (Marijuana Moment)

• South Dakota Activists Turn In Signatures To Put Marijuana Legalization On The Ballot (Marijuana Moment)

• Biden officials say Brittney Griner ‘wrongfully detained’ by Russia on cannabis charges (Leafly)

• More Ohio Cities Set To Vote On Marijuana Decriminalization As Activists Pursue Statewide Reform Initiative (Marijuana Moment)

• The Fight Over CBD Oil Continues in Germany (High Times)

• A New Report Explains How California Screwed Up Marijuana Legalization (Reason)

• Cannabis YouTuber Chrissy Harless’s Channel Deleted Without Explanation (High Times)

• Delaware House Approves Marijuana Legalization Bill, Sending It To The Senate (Marijuana Moment)

• Study Finds Cannabis Flower Useful to Decrease Fatigue (High Times)

• South Carolina Medical Marijuana Bill Dies On House Floor Following Procedural Challenge (Marijuana Moment)

• Malawi Joins Zimbabwe in Switching from Cultivating Tobacco to Cannabis (High Times)

• New York Lawmakers Discuss Competing Psychedelics Reform Bills Ahead Of Key Deadline (Marijuana Moment)

• FDA Sends Warning Letters to Businesses Improperly Selling Delta-8 (High Times)

• Missouri Marijuana Activists Say They’ve Exceeded Signature Requirements For Legalization Ballot Measures As Prospects For Separate Reform Bills Dwindle (Marijuana Moment)

• Argentina Makes Medical Cannabis Reform a National Priority (High Times)

• Nebraska Activists Unveil Plan To Put Medical Marijuana On The Ballot After Losing Key Funders (Marijuana Moment)

LSD

• LSD and salvia divinorum use linked to an increased likelihood of depression and suicidal thinking (PsyPost)

• MindBio Therapeutics Completes World’s First Microdosing Trial (Microdose)

• A Return Trip to Timothy Leary’s Psychedelic, Day-Glo Mexico (The New York Times)

• In low doses, can LSD be beneficial for the brain? (Vents Magazine)

Magic Mushrooms

• Large survey suggests psilocybin is a “relatively safe” drug, with serious reactions being rare and short-lived (PsyPost)

• Compass Pathways Shares ‘Promising’ Data That Psilocybin May Treat Anorexia (Psychedelic Spotlight)

• Canada to Fund Research on Psilocybin for Substance Use Disorder (Filter)

• Could Magic Mushrooms Treat Overeating? New Clinical Trial Intends To Find Out (The Fresh Toast)

• How to Shop For Magic Mushroom Grow Kits on Amazon (MEL Magazine)

• 4-year-old overdoses after accidently getting into a bag of Psychedelic mushrooms (WSB-TV)

Peyote

• Meet The Company Developing Innovative Peyote-Based Treatments For Addiction, Anxiety, And Depression (Benzinga)

Iboga

• Lamar Odom ‘could probably’ take hallucinogenic drug again for treatment (Page Six)

Ketamine

• Medical experts told grand jury ketamine caused Elijah McClain's death, records show (The Denver Gazette)

• Ketamine Infusions Improve Symptoms of Depression and Pain (Psychiatry Advisor)

Miscellaneous

• Elon Musk advocates for psychedelic drug use as alternative to antidepressants (MARCA)

• Why Field Trip Health Is Dividing in Two — and What This Means for Investors (Psychedelic Spotlight)

• Connecticut Lawmakers Send Psychedelic Treatment Program Proposal To Governor As Part Of Budget Bill (Marijuana Moment)

• Why Psychedelic Drugs May Become a Key Treatment for PTSD and Depression (Smithsonian Magazine)

• New holistic healing, psychedelic therapy center launches in Austin (Fox 7 Austin)

• DanceSafe have provided new guidance on how to test your drugs (Mixmag)

• Numinus’s Acquisition of Novamind May Signal More Consolidation to Come (Lucid News)

• Hallucinating Long After the Trip is Over: HPPD – Part 2 (Psychedelic Science Review)

• Psychedelic Therapists Must Be Trained to Set Sexual Boundaries (Lucid News)

• Real Reciprocity: The People Who Brought You Sacred Plant Medicine Need Your Support (Chacruna)

• Are There Risks to Using Psychedelics If You Have Certain Mental Illnesses? (Lucid News)

• Could a psychedelic retreat cure lifelong hang ups? (The Telegraph)

• Chaplains Are Learning to Become Psychedelic Guides (Lucid News)

• What Do Therapeutic Doses of Psychedelics Feel Like? (Psychology Today)

5.13.22

Cannabis

• Austin, Texas Voters Approve Local Marijuana Decriminalization Ballot Initiative (Marijuana Moment)

• Mexico’s Supreme Court rules personal marijuana possession legal, again (Leafly)

• Cannabis confusion: Thousands of truckers taken off the job amid supply chain woes (Politico)

• Sadiq Khan launches commission to examine cannabis legality (The Guardian)

• Swiss City of Lausanne to Launch Recreational Cannabis Trial This Fall (High Times)

• Thai high: Thailand to give away 1 million free marijuana plants (New York Post)

• Delaware Senate Approves Marijuana Legalization Bill, Sending It To The Governor (Marijuana Moment)

• Miami Finally Gives OK to Medical Cannabis Dispensaries (High Times)

• Ohio Will Not Vote On Marijuana This November, But Lawsuit Settlement Puts Legalization Activists On Path For 2023 (Marijuana Moment)

• Is weed the Chosen People’s drug of choice? These artifacts suggest it may be (The Times of Israel)

• South Carolina Medical Marijuana Legalization Bill Suffers Another Procedural Defeat (Marijuana Moment)

• New Hampshire Senate Rejects Marijuana Legalization Again As Part Of Amended Bill (Marijuana Moment)

• Cannabis users expect cannabis-assisted therapy for depression to work as well as psilocybin-assisted therapy (PsyPost)

• Working In Canada’s Marijuana Industry Does Not Make People Inadmissible To U.S., Border Patrol Document Confirms (Marijuana Moment)

• Missouri Activists Submit Double The Signatures Needed For Marijuana Legalization Ballot Initiative (Marijuana Moment)

• Inside one of the first licensed medical cannabis labs in Britain (The Guardian)

LSD

• Promising early results from largest-ever trial testing LSD for anxiety (New Atlas)

• Behind the Scenes on the First Study To Compare the Effects of LSD and Psilocybin (Technology Networks)

Magic Mushrooms

• Psychedelics Activists Arrested at DEA Headquarters Amid Protest Over Psilocybin Access for Terminal Patients (DoubleBlind)

• Shroom Dispensaries Operate Out in the Open in Vancouver (DoubleBlind)

• Oregon Issues Draft of Magic Mushroom Cultivation Rules (Lucid News)

MDMA

• MAPS Completes Enrollment, as Planned, for the Confirmatory Phase 3 Trial of MDMA-Assisted Therapy for PTSD (PR Newswire)

• Drug policy group condemns psychedelic research association for response to B.C. sex assault claims (CBC)

• Reducing MDMA Comedown and Risks (TalkingDrugs)

Ketamine

• Inventor of Brain-Scan Helmet Takes Ketamine to Test His Technology (Bloomberg)

• Suicidal Ideation Not Related With Psychological Pain After Receiving Ketamine (Psychiatry Advisor)

• IV Ketamine: A Possible 'Trajectory of Improvement' in Severe Depression (Medpage Today)

Miscellaneous

• Connecticut Governor Signs Bill Creating Psychedelic Treatment Program (Marijuana Moment)

• Psychedelic Patents are Broken Because the Patent System Is Broken (VICE)

• The Trials of Rick Doblin (The Cut)

• Europe’s first psychedelic drug trial firm to open in London (The Guardian)

• Novel nasal spray delivers psychedelic drugs for PTSD (Israel21c)

• Colorado Activists Collect Tens Of Thousands Of Signatures To Put Psychedelics Reform On Ballot (Marijuana Moment)

• Update on the Fight for Religious Liberties in Oregon (Psychedelics Today)

• Psychedelic experiences and mindfulness linked to better psychological wellbeing (PsyPost)

• Inside Illinois’ First Psychedelics Bill: How Advocates Are Breaking the Taboo (Psychedelic Spotlight)

• Biotechs want to unlock the psychedelics market, but it isn’t simple (The Sydney Morning Herald)

• First licence for service to test purity of illegal drugs. (The Times)

• Altering Perceptions on Psychedelics (Harvard Medicine)

5.20.22

Cannabis

• Rhode Island: Lawmakers Advance Adult-Use Legalization Bill (NORML)

• Lawmakers strike the word ‘marijuana’ from all state laws, calling the term racist (Dark Matters)

• Minnesota Republican Senators Block Marijuana Legalization Vote (Marijuana Moment)

• Study: Young Adults’ Consumption of Alcohol, Cigarettes, Other Substances Fell Following Marijuana Legalization (NORML)

• FDA Sounds Alarm About Cereal and Candy Edibles that Appeal to Children (High Times)

• Delaware: House Members Pause Action on Marijuana Retail Bill Until After Legislative Break (NORML)

• New Study Confirms Safety of CBD (High Times)

• Congress might have inadvertently legalized a form of cannabis under Trump (San Francisco Chronicle)

Magic Mushrooms

• First patient in Quebec gets approval from Health Canada for magic mushroom therapy (Global News)

MDMA

• A Brief History of MDMA: From CIA to Raves to Psychedelic Therapy (Psychedelic Spotlight)

Ayahuasca

• Tea and Ashes: How Ayahuasca Can Help You Quit Smoking (Chacruna)

Mescaline

• Mescaline: A Neglected Tool for Psychotherapy (Chemical Collective)

• Journey Colab Looks to Mescaline for Treating Alcohol Use Disorder (Lucid News)

Peyote

• ‘Our way of healing’: Azee’ Bee Nahagha working to protect peyote from state decriminalization (Navajo Times)

• What, Exactly, Is Peyote… And What Does It Do? (Rare)

Iboga

• Can Ibogaine Treat Emotional Trauma? (Lucid News)

Novel Psychoactive Substances

• MindMed Releases Phase 1 Trial Results For Opioid Addiction (Microdose)

Synthetic Cannabinoids

• Here’s What You Should Know About Synthetic Marijuana (The Fresh Toast)

Ketamine

• Ketamine, esketamine improve depression symptoms (Healio)

Datura

• Compound found in Datura shows promise as antiviral agent against SARS-CoV-2 (News-Medical.net)

Miscellaneous

• Inside the Dispute Over a High-Profile Psychedelic Study (VICE)

• 50% of Microdosers Started During Pandemic, Survey Suggests (DoubleBlind)

• Forget Burning Man — Psychedelic Shamans Now Heading to Davos (Bloomberg)

• How Will The Psychedelic Industry Affect SSRI Treatment In The U.S.? (Healing Maps)

• Psychedelics: how they act on the brain to relieve depression (The Conversation)

• Getting Buzzed: The History of Hallucinogenic Mad Honey (Ancient Origins)

5.27.22

Cannabis

• Rhode Island Becomes 19th State to Legalize Marijuana for Adults (NORML)

• Kansas Lawmakers Plan To Work On Medical Marijuana Over Summer As 2022 Session Ends (Marijuana Moment)

• New study finds cannabis effective for cancer pain (Leafly)

• California Marijuana Retailers ‘100 Percent’ Compliant In Checking IDs To Prevent Youth Access, Study Finds (Marijuana Moment)

• U.K. Caregiver Spared Jail Sentence After Cancer Patients Defend Him (High Times)

• Marijuana ‘Strain’ Labels Often Mislead Consumers, Study Of Nearly 90,000 Samples Shows (Marijuana Moment)

• North Carolina quietly moves toward full legalization of hemp (WRAL)

• Louisiana Bill to Allow State Employees to Use Medical Cannabis Receives Unanimous Vote (High Times)

• Delaware: Governor Vetoes Marijuana Depenalization Measure (NORML)

• South Dakota Voters Will Decide On Marijuana Legalization Ballot Measure In November (Marijuana Moment)

• North Carolina Lawmaker Introduces Legalization Bill (High Times)

• Federal Marijuana Arrests Continue To Drop Amid Legalization Movement, New Justice Department Report Shows (Marijuana Moment)

• Cannabis Reform Bill in South Africa Under Criticism from Unions and Rastas (High Times)

• Legalised cannabis in Canada and US hasn’t killed illegal market (New Scientist)

• Japanese Ministry of Health to Discuss Medical Cannabis Legalization (High Times)

• Texas Activists Say They’ve Collected Enough Signatures To Put Marijuana Decriminalization On Another Local Ballot (Marijuana Moment)

• What’s Up With Cannabis Legalization in Belgium? (High Times)

• Georgia Voters Approve Marijuana Legalization Ballot Question (Marijuana Moment)

• Australian Legalize Cannabis Party Runs Successful Grassroots Election Campaign (High Times)

• New York Marijuana Regulators Ask TikTok To Stop Banning Cannabis Education Advertising (Marijuana Moment)

Magic Mushrooms

• Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows (High Times)

• Senator’s Wife Secretly Gave Him Psilocybin to Alleviate Depression (Psychedelic Spotlight)

• Conflicting States of Consciousness: Exploring Psilocin and Sleep (Psychedelic Science Review)

• Oregon, Measure 109, and Community Access: The Final Vote (Psychedelics Today)

MDMA

• Diddy: Biggie's "Hypnotize" Video Shoot Was First Time We Tried Ecstasy (The Source)

• I’m a Therapist Who Tried MDMA—Here’s How the Experience Shaped My Perspective on Psychedelic Therapy (Self)

• Does Grapefruit Juice Make MDMA Stronger? (TalkingDrugs)

Ayahuasca

• Will Smith Predicted Losing His Career During Ayahuasca Hallucination Before Oscars Slap (Entertainment Online)

• Exploring the travel craze of Ayahuasca tripping to South America (Far Out Magazine)

• How To Engage In Ethical Ayahuasca Tourism (Healing Maps)

Peyote

• Legalizing peyote will 'detrimentally' affect religious practices, Navajo Nation says (12News)

Novel Psychoactive Substances

• Research Chemicals Provide Dangerous, Experimental Highs to Desperate Users (High Times)

• Psychedelic Treatment For Alcoholism? Clearmind Medicine And SciSparc Collaboration Yields Positive Results (Benzinga)

• 5 Next-Generation Psychedelics Entering Clinical Trials This Year (Psychedelic Spotlight)

• Fears over ‘worrying’ new drugs being sold at festivals (Independent.ie)

Ketamine

• Using Ketamine to Find an Undiscovered Pathway in Depression (Neuroscience News)

Miscellaneous

• Local Michigan Lawmakers Reject Psychedelics Decriminalization Over Concerns About Possible Legal Liabilities (Marijuana Moment)

• $2.7M Grant to UC Davis to Find New Addiction Treatments Related to Psychedelics (UC Davis)

• Vermont Governor Vetoes Bill On ‘Reducing The Criminalization’ Of Drugs By Setting Personal Use Amounts (Marijuana Moment)

• Colorado’s Two Psychedelic Ballot Efforts Present Competing Visions (Filter)

• DEA Loses Parking Space for its Plane (Drug WarRant)

• Psychedelic Therapy Training Programs Expand To Meet Demand (Lucid News)

• Europe’s Leading Psychedelic Conference Returns to Amsterdam (GlobeNewswire)

• Why “Drug-Induced Homicide” Doesn’t Have to be Prosecuted (Filter)

Think Wilder is reader-supported. If you enjoyed this month’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.18.22

Cannabis

• Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

• Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

• Delaware House Shoots Down Recreational Legalization Bill (High Times)

• New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

• Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

• Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

• Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

• Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

• Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

• New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

• Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

• Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

• European Commission Sets Standards for Hemp Food (High Times)

• Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

• Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

• Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

• California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

• Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

• California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

• Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

• Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

• Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

• MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

• Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

• Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

• Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

• Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

• A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

• Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

• Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

• New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

• Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

• Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

• MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

• What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

• How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

• Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

• London should pilot drug checking and consumption rooms, says report (London Evening Standard)

• Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

• Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

• Are drug wars protection rackets? (Drug WarRant)

• Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

• Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

• Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.11.22

Cannabis

• Costa Rica Moves Forward with Medical Cannabis Reform (High Times)

• New York Regulators Unanimously Advance Rule To Let People With Marijuana Convictions Open Shop Before Big Businesses Can Enter Market (Marijuana Moment)

• Morocco Moves into Medical Cannabis Cultivation (High Times)

• DC’s recreational marijuana ambitions blocked in federal bill (Marijuana Business Daily)

• NCAA Relaxes Drug Testing Policies for Cannabis (NORML)

• Kentucky Lawmakers Approve Medical Marijuana Legalization Bill In Committee (Marijuana Moment)

• Delaware: House Members Fail to Advance Legalization Legislation (NORML)

• Key GOP Kansas Lawmaker Files Medical Marijuana Legalization Bill In Senate (Marijuana Moment)

• No, The World’s Biggest Cannabis Company Is Not Russian-Owned (Forbes)

LSD

• Blackhawk's unit invests NZ$2.3M to advance microdosing LSD in phase 2 trials (Seeking Alpha)

Magic Mushrooms

• Head of Oregon’s Psilocybin Advisory Board resigns (OPB)

• Oklahoma House Passes Psilocybin Decriminalization And Research Bill, Sending It To Senate (Marijuana Moment)

• Hawaii Senate Unanimously Approves Psilocybin Task Force Bill, With Decriminalization Measures Still Pending (Marijuana Moment)

• Z Strain Mushrooms: Effects, Cultivation, and More (DoubleBlind)

• Washington State Ballot Initiative Would Legalize ‘Facilitated’ Psilocybin Sessions (Marijuana Moment)

• Demand grows for UK ministers to reclassify psilocybin for medical research (The Guardian)

Ayahuasca

• Ayahuasca and Childbirth in the Santo Daime Tradition: Solidarity Among Women and Psychedelic Cultural Resistance (Chacruna)

San Pedro

• Numinus Adds Ayahuasca & San Pedro to Federal License for Psychedelic Research (Psilocybin Alpha)

Synthetic Cannabinoids

• New Machine Learning-Based Test Could Improve Detection of Synthetic Cannabinoids (PR Newswire)

Miscellaneous

• Fireside Project’s New Equity Initiative Expands Psychedelic Support Services (Lucid News)

• Maryland House And Senate Committees Consider Drug Decriminalization Bills (Marijuana Moment)

• Rhode Island Lawmakers File Psilocybin And Broader Drug Decriminalization Bills While Legal Marijuana Momentum Increases (Marijuana Moment)

• GOP Missouri Lawmaker Files Psychedelics Therapy And Decriminalization Bill (Marijuana Moment)

• Will Psychedelics Become Commercialized Like Weed? (Westword)

• Georgia Bill Would Create Psychedelic Study Committee To Recommend Reform Policies (Marijuana Moment)

• HPPD and Flashbacks: Everything You Need To Know – And What We Don’t Know, Too (Psychedelics Today)

• Drug companies are investing big in psychedelics, but can they engineer out the trip? (Chemical and Engineering News)

• Psychedelics, the War on Drugs, and Violence in Latin America (Chacruna)

• New Age of Psychedelics (Pharmaceutical Executive)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.17.21

Cannabis

• Malta becomes first EU country to legalise cannabis for personal use (Euronews)

• St. Louis Mayor Signs Bill To Decriminalize Marijuana Possession And Cultivation (Marijuana Moment)

• No Fentanyl Found in Cannabis After All, Vermont Police Say (High Times)

• Viral story shared across social media about two teens overdosing on fentanyl-laced marijuana in Springfield was untrue (MassLive)

• Ministry pushes full cannabis legalisation (Bangkok Post)

• Government-Funded Study Shows Unprecedented Decline in Marijuana Use By Young People (NORML)

• Pfizer to Acquire Pharmaceutical Company Testing Cannabinoid Treatment (High Times)

• Heavy metals in cannabis plants could affect human health, study finds (New Atlas)

• Rhode Island Legalization Bill Set for Early 2022 Introduction (High Times)

• Baltimore: City Officials Move to Abolish Pre-Employment Drug Screens for Many Public Employees (NORML)

• Smoking CBD-Rich Marijuana Has ‘No Significant Impact’ On Driving Ability, Study Finds (Marijuana Moment)

• Cannabis use could cause harmful drug interactions (ScienceDaily)

LSD

• Cary Grant Is High on LSD in ‘Flying Over Sunset.’ Everyone Else Has a Bad Trip. (The Daily Beast)

• PharmaTher Announces Positive Research Results for LSD Microneedle Patch (BioSpace)

• MindMed Initiates Phase 2a LSD Trial for the Treatment of Adult ADHD (Psilocybin Alpha)

Magic Mushrooms

• New Filing Challenges Compass Pathways’ Infamous Patent on Synthetic Psilocybin (VICE)

• Psilocybin-assisted psychotherapy reduces loss of meaning and suicidal ideation among cancer patients (PsyPost)

• With health care workers hurting, a doctor wants to see if a psychedelic can help (NBC News)

• COMPASS Pathways announces positive outcome of 25mg COMP360 psilocybin therapy as adjunct to SSRI antidepressants in open-label treatment-resistant depression study (Psilocybin Alpha)

• More patients granted psilocybin exemption by federal government (CBC)

• Warning: Oregon Legalized Supported Adult Use of Psilocybin, Not Psychedelic Therapy (Chacruna)

• New York Lawmaker Files Bill To Legalize Medical Psilocybin Treatments, With Focus On First Responders And Veterans (Marijuana Moment)

• This Trippy New Book Takes You Through Modern Mushroom History—With Cartoons (DoubleBlind)

• Psyched Wellness Announces Path to Market for AME-1-derived Products in the USA (Psilocybin Alpha)

• Silo Wellness announces series of psilocybin retreats in Jamaica (Globetrender)

• HAVN Life Successfully Exports Psilocybin from Jamaica Facility into the U.S. for Research Purposes (Psilocybin Alpha)

MDMA

• The Big Return – and Decline in Quality – of MDMA (VICE)

• Latest trials confirm the benefits of MDMA – the drug in ecstasy – for treating PTSD (The Conversation)

• MDMA could soon be used to treat PTSD according to physicians (Mixmag)

Ayahuasca

• Study links the ceremonial use of ayahuasca to robust reductions in neuroticism (PsyPost)

• Educating Gringos in Shipibo Ways (Chacruna)

• Esther Jean Langdon: Half a Century of Research About Shamanism and Ayahuasca (Chacruna)

Novel Psychoactive Substances

• Cybin Awarded Notice of Allowance from U.S. Patent and Trademark Office for CYB004 (Deuterated Psychedelic Tryptamine) for the Treatment of Anxiety Disorders (Psilocybin Alpha)

• atai Life Sciences Announces Successful Outcome of Phase 2a Biomarker Trial of RL-007 in Cognitive Impairment Associated with Schizophrenia (Psilocybin Alpha)

Synthetic Cannabinoids

• Tainted synthetic marijuana linked to severe bleeding cases in Florida (Live Science)

Miscellaneous

• Psychedelics Rejected for Therapeutic Use in Australia (VICE)

• Can a Values-Centered Psychedelic Ecosystem Effectively Compete? (Lucid News)

• Mind Medicine Australia’s Response to the Announcement of the TGA NOT to Reschedule the Medical Use of MDMA for Treatment Resistant PTSD and the Medical Use of Psilocybin for Treatment Resistant Depression as Part of Therapy. (Mind Medicine Australia)

• How Do Psychedelics Change Your Personality? These Researchers Tried To Find Out (IFLScience)

• ‘This isn’t the 60s again’: psychedelics business takes off amid culture clash (The Guardian)

• 2022 Global Drug Survey: Help make it bigger than ever for its 10 year anniversary (TalkingDrugs)

• Most Addiction Specialists Support Legalized Therapeutic Psychedelics (Medscape)

• Psychedelic-Assisted Therapy on the Rise in VA Hospitals (Lucid News)

• Psychedelics and Substance Use Disorder: 4000 BCE to Present Day (Psychedelic Science Review)

• Many Indians Are Experimenting With Psychedelics, Other Drugs to Deal With Mental Health Issues (The Swaddle)

• Editor’s Choice Award 2021-Best Study on Psychedelics and Neuroplasticity (Psychedelic Science Review)

• atai Impact Establishes the atai Fellowship Fund in Psychedelic Neuroscience with Massachusetts General Hospital’s Center for the Neuroscience of Psychedelics (Psilocybin Alpha)

• How to Start Microdosing Psychedelics (DoubleBlind)

• Understanding HPPD to Prioritize Harm Reduction of a Very Real Psychedelic Risk (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.